SL
Sri Laxmi Telukuntla
About Sri Laxmi Telukuntla
Data last updated:
Sri Laxmi Telukuntla is a Director at Turio Pharmaceuticals Private Limited (since 2019). The company operates in Chemicals. Turio Pharmaceuticals Private Limited reported revenue of ₹16.8 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Turio Pharmaceuticals Private Limited U24299TG2019PTC136447 | Director | 29 Oct 2019 | 2019 | ₹16.8 Lakh (FY 2024) | Active |
Board colleagues of Sri Laxmi Telukuntla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rekha Telukuntla | 08639717 | Turio Pharmaceuticals Private Limited | Managing Director |
| Suresh Chaluvadi | 10397350 | Turio Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sri Laxmi Telukuntla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sri Laxmi Telukuntla
Sri Laxmi Telukuntla currently holds 1 directorship: Turio Pharmaceuticals Private Limited (Director, since 29 Oct 2019, revenue ₹16.8 Lakh (FY 2024)).
Sri Laxmi Telukuntla was first appointed on 29 Oct 2019 as Director at Turio Pharmaceuticals Private Limited.
The current boards of Sri Laxmi Telukuntla's companies include Rekha Telukuntla (Turio Pharmaceuticals Private Limited), Suresh Chaluvadi (Turio Pharmaceuticals Private Limited).